Comparison of Clinical Application of the Abbott HBV PCR Kit and the Versant HBV DNA 3.0 Test to Measure Serum Hepatitis B Virus DNA in Taiwanese Patients

Kaohsiung Journal of Medical Sciences

Volumn 25, Issue 8, 2009, Pages 413-422

  Yang, Jeng Fu ^a   Lin, Ya Yun ^a   Huang, Jee Fu ^a,b   Liu, Shu Fen ^a   Chu, Pei Yu ^c   Hsieh, Ming Yen ^a   Lin, Zu Yau ^a,b   Chen, Shinn Cherng ^a,b   Wang, Liang Yen ^a,b   Dai, Chia Yen ^a,b   Chuang, Wan Long ^a,b   Yu, Ming Lung ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

bDNA 3.0 assay; HBeAg; HBV DNA PCR Kit; HBV DNA quantification; HBV infection

Indexed keywords

ARTICLE; CHRONIC HEPATITIS; CONTROLLED STUDY; DNA DETERMINATION; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; REAL TIME POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADOLESCENT; ADULT; AGED; BIOLOGICAL ASSAY; DNA, VIRAL; FEMALE; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; TAIWAN; YOUNG ADULT;

EID: 67651246981     PISSN: 1607551X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1607-551X(09)70536-4     Document Type: Article

References (35)

1. Lee W. Hepatitis B virus infection. N Engl J Med 337 (1997) 1733-1745
2. Chen C.H., Yang P.M., Huang G.T., et al. Estimation of sero-prevalence of hepatitis B virus and hepatitis C in Taiwan from a large-scale survey of free hepatitis screening participants. J Formos Med Assoc 106 (2007) 148-155
3. Dai C.Y., Chuang W.L., Ho C.K., et al. Associations between hepatitis C viremia and low serum triglyceride and cholesterol levels: a community-based study. J Hepatol 49 (2008) 9-16
4. Stevens C., Beasley R., Tsui J., et al. Vertical transmission of hepatitis B antigen in Taiwan. N Engl J Med 292 (1975) 772-774
5. Noborg U., Gusdal A., Pisa E., et al. Automated quantitative analysis of hepatitis B virus DNA by using the Cobas Amplicor HBV Monitor test. J Clin Microbiol 37 (1999) 2793-2797
6. Chen C.J., Yang H.I., Su J., et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level. JAMA 295 (2006) 65-73
7. Jarvis B., and Faulds D. Lamivudine. A review of its therapeutic potential in chronic hepatitis B. Drugs 58 (1999) 101-141
8. Dando T., and Plosker G. Adefovir dipivoxil: a review of its use in chronic hepatitis B. Drugs 63 (2003) 2215-2234
9. Thibault V. Where does adefovir stand amongst newly developed antivirals: from pharmacology to virology. Future Virol 1 (2006) 553-565
10. Matthews S.J. Entecavir for the treatment of chronic hepatitis B virus infection. Clin Ther 28 (2006) 184-203
11. Liaw Y.F., Sung J.J., Chow W.C., et al. Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 351 (2004) 1521-1531
12. Zoulim F. New insight on hepatitis B virus persistence from the study of intrahepatic viral ccDNA. J Hepatol 42 (2005) 302-308
13. Leung N. Viral breakthrough during lamivudine therapy for chronic hepatitis B. Intervirology 46 (2003) 344-349
14. Lampertico P., Vigano M., Manenti E., et al. Adefovir rapidly suppresses hepatitis B in HBeAg-negative patients developing genotypic resistance to lamivudine. Depatology 42 (2005) 1414-1419
15. van Deursen F.J., Hino K., Wyatt D., et al. Use of PCR in resolving diagnostic difficulties potentially caused by genetic variation of hepatitis B virus. J Clin Pathol 51 (1998) 149-153
16. Zhang Y.Y., Hansson B.G., Kuo L.S., et al. Hepatitis B virus DNA in serum and liver is commonly found in Chinese patients with chronic liver disease despite the presence of antibodies to HBsAg. Hepatology 17 (1993) 538-544
17. Cacciola I., Pollicino T., Squadrito G., et al. Occult hepatitis B virus infection in patients with chronic hepatitis C liver disease. N Engl J Med 341 (1999) 22-26
18. Barlet V., Cohard M., Thelu M.A., et al. Quantitative detection of hepatitis B virus DNA in serum using chemiluminescence: comparison with radioactive solution hybridization assay. J Virol Methods 49 (1994) 141-151
19. Hendricks D.A., Stowe B.J., Hoo B.S., et al. Quantitation of HBV DNA in human serum using a branched DNA (bDNA) signal amplification assay. Am J Clin Pathol 104 (1995) 537-546
20. Pawlotsky J.M., Bastie A., Lonjon I., et al. What technique should be used for routine detection and quantification of HBV DNA in clinical samples?. J Virol Methods 65 (1997) 245-253
21. Buti M., Sanchez F., Cotrina M., et al. Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B. J Infect Dis 183 (2001) 1277-1280
22. Ranki M., Schatzl H.M., Zachoval R., et al. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection. Hepatology 21 (1995) 1492-1499
23. Jardi R., Buti M., Rodriguez-Frias F., et al. The value of quantitative detection of HBV-DNA amplified by PCR in the study of hepatitis B infection. J Hepatol 24 (1996) 680-685
24. Gerken G., Gomes J., Lampertico P., et al. Clinical evaluation and applications of the Amplicor HBV Monitor test, a quantitative HBV DNA PCR assay. J Virol Methods 74 (1998) 155-165
25. Pawlotsky J.M. Molecular diagnosis of viral hepatitis. Gastroenterology 122 (2002) 1554-1568
26. Chan H., Leung N., Hussain M., et al. Are pre-core HBV mutants becoming more prevalent?. Hepatology 28 (1998) 484A
27. Thibault V., Pichoud C., Mullen C., et al. Characterization of a new sensitive PCR assay for quantification of viral DNA isolated from patients with hepatitis B virus infection. J Clin Microbiol 45 (2007) 3948-3953
28. Juman Awadh A., Kvuregvan K.K., Isaeva K.K., et al. Comparative characterization of two tests for measurement of hepatitis B virus DNA in the blood serum and plasma, based on the use of two different detection methods. Bull Exp Biol Med 146 (2008) 246-249
29. Ronsin C., Pillet A., Bali C., et al. Evaluation of the COBAS AmpliPrep-total nucleic acid isolation-COBAS TaqMan hepatitis B virus (HBV) quantitative test and comparison to the VERSANT HBV DNA 3.0 assay. J Clin Microbiol 44 (2006) 1390-1399
30. Laperche S., Thibault V., Bouchardeau F., et al. Expertise of laboratories in viral load quantification, genotyping, and precore mutant determination for hepatitis B virus in a multicenter study. J Clin Microbiol 44 (2006) 3600-3607
31. Ho S.K., Yam W.C., Leung E.T., et al. Rapid quantitation of hepatitis B virus DNA by real-time PCR using fluorescent hybridization probes. J Med Microbiol 52 (2003) 397-402
32. Jardi R., Rodriguez F., Buti M., et al. Quantitative detection of hepatitis B virus DNA in serum by a new rapid real-time fluorescence PCR assay. J Viral Hepatol 8 (2001) 465-471
33. Tedder R.S., Ijaz S., Gilbert N., et al. Evidence for a dynamic host-parasite relationship in e-negative hepatitis B carriers. J Med Virol 68 (2002) 505-512
34. Dai C.Y., Yu M.L., Chuang W.L., et al. Clinical evaluation of the COBAS Amplicor HBV monitor test for measuring serum HBV DNA and comparison with the Quantiplex branched DNA signal amplification assay in Taiwan. J Clin Pathol 57 (2004) 141-145
35. Keeffe E., Zeuzem S., Koff R.S., et al. Report of an international workshop: roadmap for management of patients receiving oral therapy for chronic hepatitis B. Clin Gastroenterol Hepatol 5 (2007) 890-897